BioNTech SE - ADR

NASDAQ:BNTX   3:59:56 PM EDT
294.78
+16.44 (+5.91%)
Products

FDA Says Authorizes Booster Dose Of Pfizer-Biontech Covid-19 Vaccine For Certain Populations

Published: 09/22/2021 23:42 GMT
BioNTech SE - ADR (BNTX) - :fda Says Authorizes Booster Dose of Pfizer-biontech Covid-19 Vaccine for Certain Populations.
FDA Says Authorizes Booster Dose of Pfizer-biontech Covid-19 Vaccine for Individuals 65 Years of Age and Older.
FDA Says Authorizes Booster Dose of Pfizer-biontech Covid-19 Vaccine for Individuals 18 Through 64 Years of Age at High Risk of Severe Covid-19.
FDA Says Authorizes Booster Dose of Pfizer-biontech Covid-19 Vaccine for Individuals 18 Through 64 Years of Age That Puts Them at High Risk.
((reuters.
Briefs@thomsonreuters.
Com;)).